Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals Private Limited - pharma in Kaithal, Haryana, India. FY 2026 financials & compliance.
CIN U24100HR2012PTC045363 Incorporated 12 March 2012 ROC Delhi HQ Kaithal, Haryana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹76.88 Lakh
▼ 17% YoY
Net profit · FY 2025
₹22,929
Net margin 0.3%
EBITDA · FY 2025
₹2.96 Lakh
EBITDA margin 3.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
4
As per MCA filings

About Vasphar Pharmaceuticals Private Limited

Data last updated:

Vasphar Pharmaceuticals Private Limited is a private limited company based in Kaithal, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 March 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100HR2012PTC045363. Its GSTIN is 06AAECV1921E1ZP (Haryana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sneh Lata Sharma and Puneet Mittal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 88/8 Old Subzi Mandi Teh. Kaithal, Haryana, India – 136027.

As per the financials filed for FY 2025, the company reported a revenue of ₹76.88 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹22,929 (net margin 0.3%) and EBITDA of ₹2.96 Lakh (EBITDA margin 3.9%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 10% over five years.

As per MCA filings, the company has open charges of ₹30 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Vasphar Pharmaceuticals Private Limited
CIN U24100HR2012PTC045363
Registration Number 045363
Incorporation Date 12 March 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    H No. 88/8 Old Subzi Mandi Teh. Kaithal, Haryana, India – 136027
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Vasphar Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Vasphar Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Vasphar Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Vasphar Pharmaceuticals Private Limited

The main business activity of Vasphar Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Vasphar Pharmaceuticals Private Limited FY 2025 filings available

Vasphar Pharmaceuticals Private Limited reported revenue of ₹76.88 Lakh (down 17% YoY) for FY 2025.

Revenue · FY 2025
₹76.88 Lakh ▼ 17%
Net profit · FY 2025
₹22,929 margin 0.3%
EBITDA · FY 2025
₹2.96 Lakh margin 3.9%

Compounded Annual Growth Rate (CAGR) of Vasphar Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 9%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 14%
5 years · compounded
▲ 3%

Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 17% fall in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Vasphar Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹2.96 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹22,929••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Vasphar Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.9%••••••••••••••••
Net Profit Margin0.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vasphar Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vita Bio International Private Limited₹77.03 Lakh (FY 2024)••••••••43.0%••••Maharashtra, India
Lifexa Mediglobe Private Limited₹77 Lakh (FY 2025)••••••••-30.0%••••Rajkot, Gujarat, India
Rekvina Pharmaceuticals (India) Private Limited₹77 Lakh (FY 2023)••••••••4375.0%••••Mumbai, Maharashtra, India
Shree Veer Prabhu Natural Products Private Limited₹76.98 Lakh (FY 2025)••••••••271.0%••••Rehli, Madhya Pradesh, India
Hiral Remedies Private Limited₹76.97 Lakh (FY 2024)••••••••-6.0%••••Kasipur, Uttarakhand, India
Vasphar Pharmaceuticals Private Limited this company₹76.88 Lakh (FY 2025)••••••••-17.0%••••Kaithal, Haryana, India
Zwitt Pharmaceuticals Private Limited₹76.81 Lakh (FY 2025)••••••••141.0%••••Ahmedabad, Gujarat, India
Salsburg Pharmaceuticals Private Limited₹76.8 Lakh (FY 2025)••••••••9.0%••••New Delhi, Delhi, India
Unozin India Private Limited₹76.79 Lakh (FY 2025)••••••••-5.0%••••Mathura, Uttar Pradesh, India
Micropan Pharmaceuticals Private Limited₹76.72 Lakh (FY 2025)••••••••-14.0%••••Thane, Maharashtra, India
Innovative Cancer Care and Rehabilitation Private Limited₹76.71 Lakh (FY 2025)••••••••52.0%••••Faridabad, Haryana, India

Peers are the five companies nearest above and the five nearest below Vasphar Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals Private Limited is audited by RAKESH KUMAR GARG & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
RAKESH KUMAR GARG & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sneh Lata SharmaDirector12 Mar 201214 Years 6 MonthsCurrent
Puneet MittalDirector12 Mar 201214 Years 6 MonthsCurrent
Pinkey MittalDirector01 Jul 20242 Years 3 MonthsCurrent
BhumiDirector01 Jul 20242 Years 3 MonthsCurrent

Ownership and Shareholding of Vasphar Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Vasphar Pharmaceuticals Private Limited

Open charges
₹30 Lakh
Satisfied charges
None
Breakdown by lending institutions
Punjab National Bank₹0.30 Cr
Latest charge details
DateLenderAmountStatus
10 Nov 2012Punjab National Bank₹30 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Vasphar Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Vasphar Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Bhumi was appointed as Director on 01 Jul 2024.

AGM
Vasphar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vasphar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Bhumi was appointed as Director.
Appointed
Pinkey Mittal was appointed as Director.
Charges
A charge with Punjab National Bank amounted to Rs. 30.00 Lakh with Charge ID 10394736 was registered on 10 Nov 2012.
Appointed
Puneet Mittal was appointed as Director.
Appointed
Sneh Lata Sharma was appointed as Director.
Incorporation
12 Mar 2012
Vasphar Pharmaceuticals Private Limited was registered on 12 Mar 2012 with Roc Delhi & aged 14 years 6 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Vasphar Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vasphar Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vasphar Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAECV1921E1ZPHaryanaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vasphar Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vasphar Pharmaceuticals Private Limited

Vasphar Pharmaceuticals is an active private limited company based in Kaithal, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 March 2012 (14+ years old) and is registered under CIN U24100HR2012PTC045363.

Vasphar Pharmaceuticals reported revenue of ₹76.88 Lakh for FY 2025 (down 17% YoY).

Vasphar Pharmaceuticals has 4 current directors:

Vasphar Pharmaceuticals reported a net profit of ₹22,929 (net margin 0.3%) and EBITDA of ₹2.96 Lakh (EBITDA margin 3.9%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Vasphar Pharmaceuticals is -9% over three years and -10% over five years. In the latest year (FY 2025) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Vasphar Pharmaceuticals is 06AAECV1921E1ZP, registered in Haryana.

The CIN (Corporate Identification Number) of Vasphar Pharmaceuticals is U24100HR2012PTC045363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vasphar Pharmaceuticals was incorporated on 12 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Vasphar Pharmaceuticals by revenue are Vita Bio International Private Limited, Lifexa Mediglobe Private Limited, Rekvina Pharmaceuticals (India) Private Limited, Shree Veer Prabhu Natural Products Private Limited, Hiral Remedies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Bhumi was appointed as Director on 01 Jul 2024. Pinkey Mittal was appointed as Director on 01 Jul 2024. Puneet Mittal was appointed as Director on 12 Mar 2012. Vasphar Pharmaceuticals has 4 board changes on record in total.

The registered office of Vasphar Pharmaceuticals is at H No. 888 Old Subzi Mandi Teh. Kaithal, Haryana, India – 136027.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available